You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

newly diagnosed diffuse pontine tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain and CNS Tumors Trial in Memphis (GDC-0084, radiation therapy)

Completed
  • Brain and Central Nervous System Tumors
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 13, 2023

Glioblastoma, Medulloblastoma, Ependymoma Trial in Augusta, Druid Hills, Boston (Indoximod, Partial Radiation, Full-dose

Recruiting
  • Glioblastoma
  • +3 more
  • Augusta, Georgia
  • +2 more
Aug 18, 2022

Brain Cancer Trial in Canada, United States (cetuximab in conjunction with external beam radiation therapy, followed by

Completed
Has Results
  • Brain Cancer
  • cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan
  • Phoenix, Arizona
  • +11 more
Mar 2, 2022

Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Switzerland, United States

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • Los Angeles, California
  • +18 more
Aug 16, 2022

Relapsed Solid Tumor, Refractory Solid Tumor, Relapsed CNS Tumor Trial in United States (cemiplimab (monotherapy), cemiplimab

Recruiting
  • Relapsed Solid Tumor
  • +5 more
  • cemiplimab (monotherapy)
  • +3 more
  • Los Angeles, California
  • +19 more
Jan 27, 2022

Diffuse Intrinsic Pontine Glioma Trial in Houston (Radiation Therapy, Temsirolimus, Vorinostat)

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Radiation Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 5, 2022

Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)

Completed
  • Diffuse Intrinsic Pontine Glioma
  • +6 more
  • Washington, District of Columbia
  • +6 more
Jan 12, 2023

Glial Cell Tumors, Malignant Gliomas, Glioblastoma Multiforme Trial in United States (Valproic acid, Bevacizumab, Radiation

Completed
Has Results
  • Glial Cell Tumors
  • +7 more
  • Valproic acid
  • +2 more
  • Oklahoma City, Oklahoma
  • +5 more
Jun 30, 2021

Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas, Diffuse Midline Glioma Trial in New York (Infusate with

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +2 more
  • Infusate with MTX110 and gadolinium
  • Convection-Enhanced Delivery (CED)
  • New York, New York
    Columbia University Irving Medical Center
Mar 8, 2022

Diffuse Intrinsic Pontine Glioma, Medulloblastoma, Childhood, Recurrent Trial in Madrid (AloCELYVIR)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Medulloblastoma, Childhood, Recurrent
  • AloCELYVIR
  • Madrid, Spain
    Hospital Infantil Universitario Niño Jesús
Sep 29, 2022

Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

Recruiting
  • Medulloblastoma
  • +7 more
  • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
  • +2 more
  • Buffalo, New York
  • +2 more
Jul 8, 2022

Diffuse Intrinsic Pontine Glioma Trial in Aurora (Gemcitabine)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Aurora, Colorado
    Children's Hospital Colorado
Jan 31, 2022

Neuroblastoma, Diffuse Intrinsic Pontine Glioma Trial in Gainesville, Charlotte (Tumor-specific ex vivo expanded autologous

Recruiting
  • Neuroblastoma
  • Diffuse Intrinsic Pontine Glioma
  • Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)
  • Gainesville, Florida
  • +1 more
Apr 20, 2022

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • SC-CAR4BRAIN
  • Seattle, Washington
    Seattle Children's Hospital
Mar 3, 2023

Diffuse Intrinsic Pontine Glioma Trial in San Francisco (Panobinostat Nanoparticle Formulation MTX110, Convection-Enhanced

Completed
Has Results
  • Diffuse Intrinsic Pontine Glioma
  • Panobinostat Nanoparticle Formulation MTX110
  • Convection-Enhanced Delivery (CED)
  • San Francisco, California
    University of California, San Francisco
Feb 2, 2022

Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, Diffuse Glioma Trial (Re-irradiation)

Not yet recruiting
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • +5 more
  • Re-irradiation
  • (no location specified)
Oct 16, 2023

Diffuse Intrinsic Pontine Glioma, Glioma, Malignant Trial in United States (ONC201)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Glioma, Malignant
  • San Francisco, California
  • +7 more
Mar 1, 2022

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Orange, Chicago, Boston (rHSC-DIPGVax,

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Diffuse Midline Glioma, H3 K27M-Mutant
  • rHSC-DIPGVax
  • +2 more
  • Orange, California
  • +2 more
Nov 10, 2022

DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

Recruiting
  • DLBCL - Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Lenalidomide combined with G-CHOP (LO CHOP)
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Malignant Glioma, Ependymoma Trial in United States (Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields))

Active, not recruiting
  • Malignant Glioma
  • +2 more
  • Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields)
  • Concurrent Optune and RT followed by Optune System alone
  • Los Angeles, California
  • +8 more
Jan 17, 2023

Brain Stem Glioma Trial (Radiation, Atengenal, Astugenal)

Not yet recruiting
  • Brain Stem Glioma
  • Radiation
  • +2 more
  • (no location specified)
Feb 21, 2022

Diffuse Large B Cell Lymphoma Trial in Shenyang (Zanubrutinib, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Shenyang, Liaoning, China
    Xing Xiaojing
Jun 1, 2023

High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Recurrent Medulloblastoma Trial in United States (PEP-CMV, Temozolomide,

Not yet recruiting
  • High Grade Glioma
  • +2 more
  • PEP-CMV
  • +2 more
  • Aurora, Colorado
  • +9 more
Jan 28, 2022

Large B-cell Lymphoma Trial in Houston (Prednisone, Rituximab, Cyclophosphamide)

Not yet recruiting
  • Large B-cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 19, 2023